Patents by Inventor Mark Farnham

Mark Farnham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11646036
    Abstract: Systems, methods, and computer-executable instructions for identifying a candidate include receiving unscripted communication, the unscripted communication comprising communication from a first speaker. Properties of the unscripted communication are extracted. A psychographic classifier classifies the first speaker into a psychographic category based on the extracted properties. An aggregate psychographic category of a team is determined based on psychographic categories of each of the team members of the team. A weakness in the aggregate psychographic category of the team is determined. A new team member that has a psychographic category that addresses the weakness in the aggregate psychographic category of the team is identified. A recommendation that the first speaker become a team member of the team is provided.
    Type: Grant
    Filed: January 31, 2022
    Date of Patent: May 9, 2023
    Assignee: HUMANCORE LLC
    Inventors: Joseph Juhnke, Mark Farnham
  • Publication number: 20080131578
    Abstract: High concentrations of glucoraphanin, and its isothiocyanate derivative, sulforaphane, can be obtained from whole plants, plant parts or extracts obtained from a new and distinct, highly inbred, and highly self-compatible Brassica oleracea L. (Italica group) broccoli variety designated ‘Hopkins’. The new broccoli variety ‘Hopkins’ produces consistent yields of seed with a consistent high glucoraphanin concentration of greater than 60 ?mole of glucoraphanin per gram of seed (with an average range of 68-85 ?mole of glucoraphanin per gram of seed) when analyzed by Hydrophilic Interaction Liquid Chromatography (HILIC) and greater than 80 ?mol of glucoraphanin per gram of seed (with an average range of 85-105 ?mole of glucoraphanin per gram of seed) when analyzed by C18 Reverse-Phase HPLC.
    Type: Application
    Filed: October 29, 2007
    Publication date: June 5, 2008
    Inventors: Dan Caudill, Mark Farnham, Greg Rieder